Medicinal Products with Active Ingredient Golimumab
Discount agreements for finished medicinal products with the active ingredient Golimumab (ATC: L04AB06): Conclusion of non-exclusive contracts under an open-house model, accession possible at any time under the same conditions, no individual contract negotiations. Earliest contract start 01.10.2026, maximum duration 24 months, contract end 30.09.2028. Contracts may be terminated early if exclusive contracts are tendered. This is not a public contract under § 103 GWB.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 542028-2026HTML
- TED PDF — 542028-2026PDF
- TED XML — 542028-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.